comparemela.com

Page 2 - French National Academy Of Pharmacy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

GenSight Biologics Strengthens Its Management Team to Support the Launch of LUMEVOQ® in Europe

Philippe Motté as Senior VP, Regulatory and QualityMichiel Hemels as VP, Global Pricing and Market AccessPARIS (BUSINESS WIRE) Regulatory News:GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for reti.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.